103 related articles for article (PubMed ID: 9286620)
1. Serotonergic effects of dotarizine in coronary artery and in oocytes expressing 5-HT2 receptors.
Montiel C; Herrero CJ; García-Palomero E; Renart J; García AG; Lomax RB
Eur J Pharmacol; 1997 Aug; 332(2):183-93. PubMed ID: 9286620
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of blockade by the novel migraine prophylactic agent, dotarizine, of various brain and peripheral vessel contractility.
Ruiz-Nuño A; Villarroya M; Cano-Abad M; Rosado A; Balfagón G; López MG; García AG
Eur J Pharmacol; 2001 Jan; 411(3):289-99. PubMed ID: 11164387
[TBL] [Abstract][Full Text] [Related]
3. Dotarizine versus flunarizine as calcium antagonists in chromaffin cells.
Villarroya M; Gandía L; Lara B; Albillos A; López MG; García AG
Br J Pharmacol; 1995 Jan; 114(2):369-76. PubMed ID: 7881736
[TBL] [Abstract][Full Text] [Related]
4. Effects of dotarizine and flunarizine on chromaffin cell viability and cytosolic Ca2+.
Novalbos J; Abad-Santos F; Zapater P; Cano-Abad MF; Moradiellos J; Sánchez-García P; García AG
Eur J Pharmacol; 1999 Feb; 366(2-3):309-17. PubMed ID: 10082213
[TBL] [Abstract][Full Text] [Related]
5. Novel antimigraineur dotarizine releases Ca2+ from caffeine-sensitive Ca2+ stores of chromaffin cells.
Novalbos J; Abad-Santos F; Zapater P; Alvarez J; Alonso MT; Montero M; García AG
Br J Pharmacol; 1999 Oct; 128(3):621-6. PubMed ID: 10516641
[TBL] [Abstract][Full Text] [Related]
6. Memory effects of the Ca2+ and 5-HT antagonists dotarizine and flunarizine.
Petkov VD; Konstantinova E; Petkov VV; Belcheva S; Kehayov R; Vaglenova J
Acta Physiol Pharmacol Bulg; 2000; 25(2):43-50. PubMed ID: 11140170
[TBL] [Abstract][Full Text] [Related]
7. Effects of the calcium channel blockers Dotarizine and Flunarizine on cerebrovascular reactivity.
Czernicki Z; Jurkiewicz J; Bojanowski K; Piechnik S; Cervos-Navarro J
J Neurol Sci; 1996 Nov; 143(1-2):60-3. PubMed ID: 8981299
[TBL] [Abstract][Full Text] [Related]
8. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
9. Antimigraine dotarizine blocks P/Q Ca2+ channels and exocytosis in a voltage-dependent manner in chromaffin cells.
Ruiz-Nuño A; Mayorgas I; Hernández-Guijo JM; Olivares R; García AG; Gandía L
Eur J Pharmacol; 2003 Nov; 481(1):41-50. PubMed ID: 14637173
[TBL] [Abstract][Full Text] [Related]
10. Vasostabilizing effect of Dotarizine (Ca(2+)-channel blocker) on cerebrovascular reactivity in rabbits.
Kuridze N; Czernicki Z; Jarus-Dziedzic K; Jurkiewicz J; Cervos-Navarro J
Neurol Res; 2000 Mar; 22(2):229-32. PubMed ID: 10763515
[TBL] [Abstract][Full Text] [Related]
11. Behavioral effects of the Ca2+/5-HT antagonist dotarizine.
Petkov VD; Belcheva S; Konstantinova E; Vaglenova J; Petkov VV
Acta Physiol Pharmacol Bulg; 1994; 20(1):9-17. PubMed ID: 7892769
[TBL] [Abstract][Full Text] [Related]
12. Effects on nociception of the Ca2+ and 5-HT antagonist dotarizine and other 5-HT receptor agonists and antagonists.
Belcheva S; Petkov VD; Konstantinova E; Petkov VV; Boyanova E
Acta Physiol Pharmacol Bulg; 1995; 21(4):93-8. PubMed ID: 8830881
[TBL] [Abstract][Full Text] [Related]
13. Albumin prevents mitochondrial depolarization and apoptosis elicited by endoplasmic reticulum calcium depletion of neuroblastoma cells.
Gallego-Sandín S; Novalbos J; Rosado A; Cano-Abad MF; Arias E; Abad-Santos F; García AG
Eur J Pharmacol; 2005 Sep; 520(1-3):1-11. PubMed ID: 16153637
[TBL] [Abstract][Full Text] [Related]
14. Regional differences of cerebrovascular reactivity effected by calcium channel blocker - dotarizine.
Kuridze N; Czernicki Z; Jarus-Dziedzic K; Jurkiewicz J; Cervos-Navarro J
J Neurol Sci; 2000 Apr; 175(1):13-6. PubMed ID: 10785251
[TBL] [Abstract][Full Text] [Related]
15. 'Wide-spectrum Ca2+ channel antagonists': lipophilicity, inhibition, and recovery of secretion in chromaffin cells.
Lara B; Gandía L; Torres A; Olivares R; Martínez-Sierra R; García AG; López MG
Eur J Pharmacol; 1997 Apr; 325(1):109-19. PubMed ID: 9151946
[TBL] [Abstract][Full Text] [Related]
16. Effect of dotarizine on K(+)-stimulated [3H]-serotonin and [3H]-acetylcholine release from rat hippocampus.
Hadjiivanova C; Petkov VD; Maslarov D; Totev A; Panova Y; Belcheva I
Gen Pharmacol; 1997 Jan; 28(1):129-32. PubMed ID: 9112089
[TBL] [Abstract][Full Text] [Related]
17. Effects of dotarizine on 45Ca2+ movements and contractile responses in vascular smooth muscle.
Tejerina T; Chulia T; Gonzalez P
Eur J Pharmacol; 1993 Aug; 239(1-3):75-81. PubMed ID: 8223916
[TBL] [Abstract][Full Text] [Related]
18. Behavioral changes as a result of dotarizine or flunarizine influence on dopaminergic neurotransmission in the striatum.
Petkov VD; Petkova B
Acta Physiol Pharmacol Bulg; 1998; 23(1):21-5. PubMed ID: 10347616
[TBL] [Abstract][Full Text] [Related]
19. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
20. [The effects of a novel Ca2+ channel blocker, KB-2796, on 5-HT-induced responses].
Fujishima Y; Hara H; Shimazawa M; Yokota K; Sukamoto T
Nihon Yakurigaku Zasshi; 1994 Jul; 104(1):19-29. PubMed ID: 8076888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
